Sanofi Consumer Health Zantac Product Recall (2019-10-18)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Zantac 75 mg Tablet;
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| All lots | - Recalling Firm
- Sanofi Consumer Health Inc.
| B. Zantac 150 mg Tablet | DIN 02277301 | Tablet | Ranitidine 150 mg |
| All lots | - Recalling Firm
- Sanofi Consumer Health Inc.
| A. Zantac 75 mg Tablet | DIN 02230287 | Tablet | Ranitidine 75 mg |
-
Zantac 75 mg Tablet;
-
Zantac 150 mg Tablet
Affected lots may be manufactured with an API containing an impurity, N-nitrosodimethylamine (NDMA).
Wholesalers, Healthcare Establishments, Retailers